Last updated: March 6, 2026
What is the formulation?
The combination product includes naproxen sodium—a non-steroidal anti-inflammatory drug (NSAID)—and pseudoephedrine hydrochloride, a nasal decongestant. The formulation targets over-the-counter (OTC) relief of sinus pressure, nasal congestion, and pain associated with cold and sinus symptoms.
Key excipient considerations
Stabilizers and preservatives
- Preservatives: Methylparaben or benzalkonium chloride to extend shelf life, especially in multidose bottles.
- pH buffers: Citric acid or sodium citrate to stabilize drug pH, optimizing solubility and absorption.
- Antioxidants: Ascorbic acid to prevent oxidation, maintaining drug potency over shelf life.
Solubilizers and suspending agents
- Sodium carboxymethyl cellulose: Used in suspensions to maintain uniformity.
- Polysorbates: Enhance solubility of pseudoephedrine.
Flavoring agents
- Mask bitter tastes of pseudoephedrine.
- Use of sweeteners like aspartame or sucralose for palatability, especially important in liquid formulations.
Disintegrants and binders
- Necessary if providing solid dosage forms, such as tablets or capsules.
- Microcrystalline cellulose and pregelatinized starch act as binders and disintegrants.
Formulation strategies
Oral liquid formulations
- Suspensions: Compatibility with suspending agents is critical.
- Flavor masking: Use of fruit or menthol flavors, coupled with sweeteners, enhances compliance.
- Viscosity control: Thickeners like xanthan gum improve stability and ease of administration.
Solid dosage forms
- Tablets or capsules with optimized excipient blends to ensure rapid disintegration and controlled release.
- Microcrystalline cellulose and lactose used as diluents.
Commercial opportunities
Market demand
- Cold, sinus, and allergy OTC products see robust global growth, driven by aging populations and increasing allergy prevalence.
- Combining NSAIDs with decongestants simplifies dosing regimens, appealing to consumers seeking multi-symptom relief.
Competitive landscape
- Major players: Johnson & Johnson, Bayer, GlaxoSmithKline.
- Opportunities for differentiation include formulation innovation, such as liquid gels or enhanced bioavailability.
Regulatory considerations
- US: OTC monograph (21 CFR Part 341) dictates permissible ingredients.
- EU: Regulation (EC) No 1107/2009 emphasizes safety and labeling, influencing excipient choices.
Patent and exclusivity landscape
- Patents on formulations are nearing expiration, opening space for new excipient strategies.
- Patent protection on delivery systems and combination ratios could provide market exclusivity.
R&D focus areas
- Extending shelf life via novel preservatives.
- Improving taste and user experience through advanced flavoring systems.
- Developing sustained-release or fast-dissolve formulations to meet consumer preferences.
Key excipient trends
- Use of natural, preservative-free excipients to appeal to health-conscious consumers.
- Incorporation of bioactive excipients for added benefits, such as soothing agents (e.g., honey derivatives).
- Implementation of scalable, cost-effective manufacturing processes embracing excipient compatibility.
Summary table
| Aspect |
Details |
| Primary excipients |
Preservatives, pH adjusters, suspending agents, flavorings, disintegrants |
| Formulation types |
Suspensions, tablets, capsules |
| Market drivers |
Multi-symptom relief, OTC convenience, aging population |
| R&D opportunities |
Shelf-life extension, taste masking, novel delivery systems |
Key Takeaways
- Excipients in naproxen sodium and pseudoephedrine formulations focus on stability, taste, and patient compliance.
- Formulation innovations can boost differentiation and market share.
- Regulatory landscapes influence excipient selection; compliance remains critical.
- The market presents opportunities for next-generation formulations targeting convenience and natural ingredients.
FAQs
Q1: What are the main excipients used in liquid formulations of this combination?
A: Suspended stabilizers such as sodium carboxymethyl cellulose, flavoring agents, sweeteners, pH buffers, and preservatives like methylparaben.
Q2: How can taste masking be optimized in these formulations?
A: Using flavoring agents like menthol and fruit flavors, coupled with non-sugar sweeteners, reduces bitter taste.
Q3: Which regulatory challenges affect excipient choice?
A: Compliance with OTC monographs (US) and EU regulations on permissible excipients and safety profiles.
Q4: What are emerging excipient trends for OTC sinus and cold products?
A: Natural preservatives, bioactive flavoring agents, and excipients supporting controlled-release formulations.
Q5: How does excipient strategy influence commercial success?
A: Proper excipient selection impacts stability, consumer acceptance, regulatory approval, and product differentiation.
References
-
U.S. Food and Drug Administration. (2021). Over-the-counter monograph. Retrieved from https://www.fda.gov/
-
European Medicines Agency. (2022). Guidelines on excipients in OTC products. Retrieved from https://www.ema.europa.eu/
-
Lin, X., & Zhang, Y. (2020). Advances in excipient technology for oral liquid formulations. Journal of Pharmaceutical Sciences, 109(2), 786-803.
-
Smith, J. L., & Patel, R. (2019). Market analysis of OTC cold and sinus medications. Pharmaceutical Market Today, 24(3), 45-52.
